iShares Nasdaq Biotechnology $229.62

down -1.37


24/4/2014 08:10 PM  |  NASDAQ : IBB
Get Trend Analysis Icon Get IBB Trend Analysis - it has outperformed the S&P 500 by 16%

Partner Headlines

  1. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  2. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  3. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  4. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  5. Biotech ETFs Come Back Down To Earth

    Benzinga
  6. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, FB, KING)

    Benzinga
  7. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  8. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  9. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  10. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  11. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  12. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  13. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  14. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  15. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  16. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  17. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  18. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  19. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  20. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  21. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  22. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  23. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  24. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  25. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  26. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  27. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  28. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  29. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  30. S&P Likes a Trio of Biotech ETFs

    Benzinga
  31. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  32. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  33. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  34. When Cheaper Is Better With ETFs

    Benzinga
  35. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  36. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  37. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  38. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  39. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  40. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  41. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  42. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  43. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
  44. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga
  45. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
  46. Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, IBB, XBI)

    Benzinga
  47. ETFs to Watch February 13, 2012

    Benzinga
  48. ETFs to Watch February 8, 2012

    Benzinga
  49. ETFs to Watch January 5, 2012

    Benzinga
  50. Twelve For '12: Sector ETFs to Watch In The New Year

    Benzinga
Trading Center